-
公开(公告)号:US20150064281A1
公开(公告)日:2015-03-05
申请号:US14391559
申请日:2013-04-04
Applicant: ROHTO PHARMACEUTICAL CO., LTD.
Inventor: Kazuhiro Fukushima , Mariyo Kato , Yoshihiro Takai , Masashi Itoh
IPC: A61K31/155 , A61K33/30
CPC classification number: A61K31/155 , A61K31/785 , A61K33/22 , A61K33/30 , A61L12/142 , A61K2300/00
Abstract: The present invention provides an ophthalmic composition containing (A) a biguanide-based disinfectant and (B) zinc chloride. According to the present invention, an ophthalmic composition having remarkably increased disinfection effects against Acanthamoeba is provided.
Abstract translation: 本发明提供含有(A)双胍类消毒剂和(B)氯化锌的眼用组合物。 根据本发明,提供了对棘阿米巴具有显着提高的消毒效果的眼用组合物。
-
公开(公告)号:US09724312B2
公开(公告)日:2017-08-08
申请号:US14154688
申请日:2014-01-14
Applicant: ROHTO PHARMACEUTICAL CO., LTD.
Inventor: Takahiro Kurose , Takayuki Miyano , Mariyo Kato , Yoshihiro Takai
CPC classification number: A61K31/121 , A61K9/0048 , A61K9/0053 , A61K45/06 , A61K47/02 , A61K47/26 , A61K47/44
Abstract: A prophylactic, ameliorating or therapeutic agent for a retinal disease, the agent comprising geranylgeranylacetone which (a) is a mixture of (5E,9E,13E)-geranylgeranylacetone and (5Z,9E,13E)-geranylgeranylacetone, the (5E,9E,13E)-geranylgeranylacetone content of the mixture being 80% by weight or more, (b) consists of (5E,9E,13E)-geranylgeranylacetone, or (c) consists of (5Z,9E,13E)-geranylgeranylacetone directly suppresses the death of a retinal cell, thereby fundamentally preventing, ameliorating or treating the retinal disease.
-